The companies are looking to get Relistor approved for the treatment of opioid-induced constipation (:OIC) in patients taking opioids for chronic non-cancer pain. Relistor is a peripherally acting ...
Salix Pharmaceuticals has launched the first connected TV commercial for its opioid-induced constipation drug Relistor and is relying on an unusual, animated character to help lead the push. The new ...
Marketing Approval Expands Treatment to Include Nearly 11 Million Patients Who Experience Opioid-Induced Constipation While Taking Opioids for Chronic Non-Cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- ...
Data from a Post-Hoc Analysis Supports the Use of Salix's RELISTOR for Patients with Opioid-Induced Constipation and Advanced Illness in the Emergency Department Setting LAVAL, QC, Dec. 22, 2021 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Relistor is a drug that people use to treat constipation that opioid medications can cause. Relistor is effective because it does so without reducing the pain-relieving effects of the opioid drugs.
BRIDGEWATER, N.J., June 3, 2021 /PRNewswire/ -- Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of ...
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...
LAVAL, Quebec and TARRYTOWN, N.Y., April 24, 2015 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that ...
Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals, Inc., announced that the companies have received marketing approval for RELISTOR (methylnaltrexone bromide) subcutaneous ...
NEW YORK, Oct 14 (Reuters) - Progenics Pharmaceuticals Inc said on Wednesday it reached a deal with Wyeth to regain worldwide rights to Relistor, a medicine used to treat constipation caused by opioid ...
Salix Pharmaceuticals (NASDAQ:SLXP) is a step closer to bringing to the U.S. Food and Drug Administration a once-a-day pill version of injectable constipation drug Relistor. Discover the top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results